Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 656-662

  LeRiche, Vince K ^b   Asa, Sylvia L ^b   Ezzat, Shereen ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CANCER INVASION; CORRELATION FUNCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; ANTIBODIES, MONOCLONAL; BASE SEQUENCE; CULTURE MEDIA, CONDITIONED; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; GROWTH HORMONE; HUMANS; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; PITUITARY NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER;

EID: 0030064976     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.656     Document Type: Article

References (44)

1. Kovacs K, Horvath E, Asa SL. 1985 Classification and pathology of pituitary tumors. In: Wilkins RH, Rengachary SS, eds. Neurosurgery. New York: McGraw-Hill; 834-842.
2. Kovacs K, Horvath E. 1986 Tumors of the pituitary gland, fascicle 21, 2nd series. Atlas of tumor pathology. Washington DC: Armed Forces Institute of Pathology.
3. s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 330:566-568.
4. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
5. Brystom C, Larsson C, Blomberg C, Sandelin K, Falkmer E. 1990 Localization of the MEN-1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA. 87:1968-1972.
6. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL. 1992 Ras mutations in human pituitary tumors. J Clin Endocrinol Metab. 74:914-919.
7. Herman V, Drazin NZ, Gonsky R, Melmed S. 1993 Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab. 77:50-55.
8. Pei L, Melmed S, Scheithauer B, Kovacs K, Prager D. 1994 H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab. 78:842-846.
9. Cai WY, Alexander JM, Hedley-Whyte ET, et al. 1994 Ras mutations in human prolactinomas and pituitary carcinomas. J Clin Endocrinol Metab. 78:89-93.
10. Sumi T, Stefaneanu L, Kovacs K, Asa SL, Rindi G. 1993 Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocr Pathol. 4:95-99.
11. Alvaro V, Lévy L, Dubray C, et al. 1993 Invasive human pituitary tumors express a point-mutated α-protein kinase-C. J Clin Endocrinol Metab. 77:1125-1129.
12. Cryns VL, Alexander JM, Klibanski A, Arnold A. 1993 The retinoblastoma gene in human pituitary tumors. J Clin Endocrinol Metab. 77:644-646.
13. Zhu J, Leon SP, Beggs AH, Busque L, Gilliland DG, Black PM. 1994 Human pituitary adenomas show no loss of heterozygosity at the retinoblastoma gene locus. J Clin Endocrinol Metab. 78:922-927.
14. Woloschak M, Roberts JL, Post KD. 1994 Loss of heterozygosity at the retinoblastoma locus in human pituitary tumors. Cancer. 74:693-696.
15. Cross M, Dexter TM. 1991 Growth factors in development, transformation, and tumorigenesis. Cell. 64:271-280.
16. Lang RA, Burgess AW. 1990 Autocrine growth factors and tumourigenic transformation. Immunol Today. 11:244-249.
17. Sporn MB, Todaro GJ. 1980 Autocrine secretion and malignant transformation of cells. N Engl J Med. 303:878-880.
18. Heldin C-H, Westermark B. 1989 Growth factors as transforming proteins. Eur J Biochem. 184:487-496.
19. Aaronson SA. 1991 Growth factors and cancer. Science. 254:1146-1152.
20. Ezzat S, Melmed S. 1990 The role of growth factors in the pituitary. J Endocrinol Invest. 13:691-698.
21. Goldman R, Levy RB, Peles E, Yarden Y. 1990 Heterodimerization of the erbB-1 and erbB-2 receptors in human breast carcinoma cells: a mechanism for receptor transregulation. Biochem J. 29:11024-11028.
22. Kokai Y, Meyers JN, Wada T, et al. 1989 EGF-receptor and p185. Biochemistry. 5829:287-292.
23. Qian X, LeVea CM, Freeman JK, Dougall WC, Greene MI. 1994 Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation. Proc Natl Acad Sci USA. 91:1500-1504.
24. Ellis C, Moran M, McCormick F, Pawson T. 1990 EGF receptor signal transduction. Sci Nature. 335:377-381.
25. Ikeda H, Mitsuhashi T, Kubota K, Kuzuya N, Uchimura H. 1984 Epidermal growth factor stimulates growth hormone secretion from superfused rat adenohypophyseal fragments. Endocrinology. 115:556-558.
26. White BA, Bancroft FC. 1983 Epidermal growth factor and thyrotropin-releasing hormone interact synergistically with calcium to regulate prolactin mRNA levels. J Biol Chem. 258:4618-4622.
27. Murdoch GH, Potter E, Nicolaisen AK, Evans RM, Rosenfeld MG. 1982 Epidermal growth factor rapidly stimulates prolactin gene transcription. Nature. 300:192-194.
28. Polk DH, Ervin MG, Padbury JF, Lam RW, Reviczky AL, Fisher DA. 1987 Epidermal growth factor acts as a corticotropin-releasing factor in chronically catheterized fetal lambs. J Clin Invest. 79:984-988.
29. Ramsdell JS, Tashjian AH. 1985 Thyrotropin-releasing hormone and epidermal growth factor stimulate prolactin synthesis by a pathway(s) that differs from that used by phorbol esters: dissociation of actions by calcium dependency and additivity. Endocrinology. 117:2050-2060.
30. Unabia G, Rougeau D, Patterson J, Childs GV. Epidermal growth factor (EGF) and corticotrope functions [Abstract]. Proc of the 73rd Annual Meet of The Endocrine Soc. 1991; 149.
31. DiMarco E, Pierce JH, Fleming TP, et al. 1989 Autocrine interaction between TGFα and the EGF receptor: quantitative requirements for induction of the malignant phenotype. Oncogene. 4:831-838.
32. Wong AJ, Ruppert JM, Bigner SH, et al. 1992 Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci USA. 89:2965-2969.
33. Ekstrand AJ, Sugawa N, James CD, Collins VP. 1992 Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails. Proc Natl Acad Sci USA. 89:4309-4313.
34. Schlegel J, Merdes A, Stumm G, et al. 1994 Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer. 56:72-77.
35. HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci USA. 84:7159-7163.
36. Ezzat S, Walpola IA, Ramyar L, Smyth HS, Asa SL. 1995 Membrane-anchored expression of transforming growth factor-α in human pituitary adenoma cells. J Clin Endocrinol Metab. 80:534-539.
37. Ezzat S, Smyth HS, Ramyar L, Asa SL. 1995 Heterogeneous in vivo and in vitro expression of basic fibroblast growth factor in human sporadic pituitary adenomas. J Clin Endocrinol Metab. 80:878-884.
38. Bell GI, Fong NM, Stempien MM, et al. 1986 Human epidermal growth factor precursor: cDNA sequence in vitro and gene organization. Nucleic Acids Res. 14:8427-8446.
39. Ullrich A, Coussens L, Hayflick JS, et al. 1984 Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature. 309:418-425.
40. Michelson AM, Markham AF, Orkin SH. 1983 Isolation and DNA sequence of a full-length cDNA clone for human X chromosome-encoded phosphoglycerate kinase. Genetics. 80:472-476.
41. Horvath E, Kovacs K, Smyth HS, et al. 1988 A novel type of pituitary adenoma: morphological feature and clinical correlations. J Clin Endocrinol Metab. 66: 1111-1118.
42. 3 cell line. Endocrinology. 127:13-20.
43. Birman P, Michard M, Li JY, Peillon F, Bression D. 1987 Epidermal growth factor-binding sites, present in normal human and rat pituitaries, are absent in human pituitary adenomas. J Clin Endocrinol Metab. 65:275-281.
44. Takiino H, Herman V, Weiss M, Melmed S. 1995 Purine-binding factor (nm23) gene expression in pituitary tumors: Marker of adenoma invasiveness. J Clin Endocrinol Metab. 80:1733-1738.